StockNews.com began coverage on shares of Nevro (NYSE:NVRO – Free Report) in a report published on Saturday morning. The brokerage issued a hold rating on the medical equipment provider’s stock.

Buy Tesla,' Commerce chief Lutnick urges as Musk leads DOGE for Trump administration European leaders push for even more defense spending DOGE doxx site maps 'Musk World' as Trump AG threatens ...

PDN is a type of nerve damage caused by diabetes that leads to chronic pain, particularly in the feet and legs. With 10 kHz Therapy, Nevro’s SCS systems have shown promising clinical outcomes in ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Barcelona forward Raphinha is out on his own as the top scorer in this season's UEFA Champions League with 11 goals as the race heats up. The Brazilian international struck eight times in the ...

Nevro Corp是一家全球医疗器械公司，专注于提供继续为慢性疼痛治疗持久患者结果设定标准的全面的、改变生活的解决方案。该公司开发并商业化Senza脊髓刺激（SCS）系统。SCS是一个用于治疗慢性疼痛的神经调节平台，除了Senza系列产品之外，还包括Senza Omnia平台 ...

REDWOOD CITY, Calif. (AP) — REDWOOD CITY, Calif. (AP) — Nevro Corp. (NVRO) on Tuesday reported a loss of $53.1 million in its fourth quarter. On a per-share basis, the Redwood City ...

As previously announced on February 6, given the pending acquisition of Nevro (NVRO) by Globus Medical, Nevro is not issuing FY25 guidance, nor is the company holding an earnings conference call ...

REDWOOD CITY, Calif., March 4, 2025 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic ...